BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Accenture
Baxter
Federal Trade Commission
Chubb
Deloitte
McKesson
Medtronic
Covington
US Department of Justice

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,887,459

« Back to Dashboard

Which drugs does patent 6,887,459 protect, and when does it expire?

Patent 6,887,459 protects FORADIL and is included in one NDA.

This patent has twenty-eight patent family members in twenty-two countries.
Summary for Patent: 6,887,459
Title: Aerosol composition comprising formoterol
Abstract:The use of a dry powder comprising (A) formoterol, or a pharmaceutically acceptable salt or solvate thereof, or solvate of said salt, and (B) a pharmaceutically acceptable particulate diluent or carrier in an amount of from 400 .mu.g to 5000 .mu.g per .mu.g of (A) for the preparation of an inhalable medicament for the treatment of chronic obstructive pulmonary disease.
Inventor(s): Haeberlin; Barbara (Muenchenstein, CH)
Assignee: Novartis, AG (Basel, CH)
Application Number:10/148,043
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Drugs Protected by US Patent 6,887,459

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Novartis FORADIL formoterol fumarate POWDER;INHALATION 020831-001 Feb 16, 2001 DISCN Yes No ➤ Subscribe ➤ Subscribe TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,887,459

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9928311Nov 30, 1999
PCT Information
PCT FiledNovember 28, 2000PCT Application Number:PCT/EP00/11894
PCT Publication Date:June 07, 2001PCT Publication Number: WO01/39745

International Patents Family Members for US Patent 6,887,459

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2837401 ➤ Subscribe
Australia 769765 ➤ Subscribe
Brazil 0015908 ➤ Subscribe
Canada 2389349 ➤ Subscribe
China 1399540 ➤ Subscribe
Czech Republic 20021850 ➤ Subscribe
European Patent Office 1233757 ➤ Subscribe
European Patent Office 2011484 ➤ Subscribe
European Patent Office 3050558 ➤ Subscribe
Spain 2178943 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
UBS
Chinese Patent Office
Fish and Richardson
AstraZeneca
Daiichi Sankyo
Argus Health
Dow
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot